ECL

ECL
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.165B ▲ | $1.105B ▲ | $585M ▲ | 14.046% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.025B ▲ | $1.092B ▲ | $524.2M ▲ | 13.023% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.695B ▼ | $1.051B ▼ | $402.5M ▼ | 10.893% ▼ | $1.42 ▼ | $818.2M ▼ |
| Q4-2024 | $4.005B ▲ | $1.052B ▲ | $472.9M ▼ | 11.807% ▼ | $1.67 ▼ | $848.5M ▼ |
| Q3-2024 | $3.998B | $1.028B | $736.5M | 18.419% | $2.6 | $1.303B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.956B ▲ | $23.898B ▲ | $14.144B ▼ | $9.719B ▲ |
| Q2-2025 | $1.921B ▲ | $23.736B ▲ | $14.385B ▲ | $9.32B ▲ |
| Q1-2025 | $1.163B ▼ | $22.366B ▼ | $13.463B ▼ | $8.876B ▲ |
| Q4-2024 | $1.257B ▼ | $22.388B ▲ | $13.599B ▲ | $8.757B ▲ |
| Q3-2024 | $1.261B | $22.102B | $13.526B | $8.548B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M ▼ | $369.4M ▼ | $-224M ▲ | $-241.6M ▼ | $-94.2M ▼ | $131.5M ▼ |
| Q4-2024 | $492.4M ▼ | $766.7M ▼ | $-627.5M ▼ | $-140.1M ▲ | $-4.3M ▼ | $407M ▼ |
| Q3-2024 | $736.5M | $786.7M | $639.1M | $-548.3M | $877.1M | $550.3M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.37Bn ▲ | $1.42Bn ▲ | $1.54Bn ▲ | $1.59Bn ▲ |
Global Life Sciences | $0 ▲ | $170.00M ▲ | $190.00M ▲ | $180.00M ▼ |
Global Pest Elimination | $300.00M ▲ | $280.00M ▼ | $320.00M ▲ | $330.00M ▲ |
Global Water | $0 ▲ | $1.83Bn ▲ | $1.98Bn ▲ | $2.05Bn ▲ |
Global Healthcare and Life Sciences | $320.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Global Industrial | $2.07Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Ecolab looks like a mature, steadily growing industrial solutions company with an improving earnings profile, a solid but leveraged balance sheet, and strong cash generation. Its deep customer integration, service-heavy model, and proprietary digital platforms create a durable competitive position, while its focus on water, energy efficiency, and hygiene aligns with global sustainability and regulatory tailwinds. Key things to watch include how well it manages its debt load in a changing interest-rate environment, its ability to sustain margin gains if economic conditions soften, and the continued success of its innovation efforts in high-growth areas such as life sciences, data centers, and advanced digital solutions.
NEWS
November 14, 2025 · 8:30 AM UTC
Ecolab Strengthens Integrated Cooling Program for Data Centers
Read more
November 7, 2025 · 2:00 PM UTC
Ecolab Schedules Webcast of Industry Conference for November 11, 2025
Read more
November 4, 2025 · 8:30 AM UTC
Ecolab Expands Partnership with The Home Depot to Launch Exclusive Product Line in Canada
Read more
October 30, 2025 · 8:30 AM UTC
2025 Ecolab Watermark™ Study Reveals Hidden Impact of Artificial Intelligence
Read more
October 30, 2025 · 6:00 AM UTC
First Close of Emerald Global Water Fund II Reaches EUR 60 Million
Read more
About Ecolab Inc.
https://www.ecolab.comEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.165B ▲ | $1.105B ▲ | $585M ▲ | 14.046% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.025B ▲ | $1.092B ▲ | $524.2M ▲ | 13.023% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.695B ▼ | $1.051B ▼ | $402.5M ▼ | 10.893% ▼ | $1.42 ▼ | $818.2M ▼ |
| Q4-2024 | $4.005B ▲ | $1.052B ▲ | $472.9M ▼ | 11.807% ▼ | $1.67 ▼ | $848.5M ▼ |
| Q3-2024 | $3.998B | $1.028B | $736.5M | 18.419% | $2.6 | $1.303B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.956B ▲ | $23.898B ▲ | $14.144B ▼ | $9.719B ▲ |
| Q2-2025 | $1.921B ▲ | $23.736B ▲ | $14.385B ▲ | $9.32B ▲ |
| Q1-2025 | $1.163B ▼ | $22.366B ▼ | $13.463B ▼ | $8.876B ▲ |
| Q4-2024 | $1.257B ▼ | $22.388B ▲ | $13.599B ▲ | $8.757B ▲ |
| Q3-2024 | $1.261B | $22.102B | $13.526B | $8.548B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M ▼ | $369.4M ▼ | $-224M ▲ | $-241.6M ▼ | $-94.2M ▼ | $131.5M ▼ |
| Q4-2024 | $492.4M ▼ | $766.7M ▼ | $-627.5M ▼ | $-140.1M ▲ | $-4.3M ▼ | $407M ▼ |
| Q3-2024 | $736.5M | $786.7M | $639.1M | $-548.3M | $877.1M | $550.3M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.37Bn ▲ | $1.42Bn ▲ | $1.54Bn ▲ | $1.59Bn ▲ |
Global Life Sciences | $0 ▲ | $170.00M ▲ | $190.00M ▲ | $180.00M ▼ |
Global Pest Elimination | $300.00M ▲ | $280.00M ▼ | $320.00M ▲ | $330.00M ▲ |
Global Water | $0 ▲ | $1.83Bn ▲ | $1.98Bn ▲ | $2.05Bn ▲ |
Global Healthcare and Life Sciences | $320.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Global Industrial | $2.07Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Ecolab looks like a mature, steadily growing industrial solutions company with an improving earnings profile, a solid but leveraged balance sheet, and strong cash generation. Its deep customer integration, service-heavy model, and proprietary digital platforms create a durable competitive position, while its focus on water, energy efficiency, and hygiene aligns with global sustainability and regulatory tailwinds. Key things to watch include how well it manages its debt load in a changing interest-rate environment, its ability to sustain margin gains if economic conditions soften, and the continued success of its innovation efforts in high-growth areas such as life sciences, data centers, and advanced digital solutions.
NEWS
November 14, 2025 · 8:30 AM UTC
Ecolab Strengthens Integrated Cooling Program for Data Centers
Read more
November 7, 2025 · 2:00 PM UTC
Ecolab Schedules Webcast of Industry Conference for November 11, 2025
Read more
November 4, 2025 · 8:30 AM UTC
Ecolab Expands Partnership with The Home Depot to Launch Exclusive Product Line in Canada
Read more
October 30, 2025 · 8:30 AM UTC
2025 Ecolab Watermark™ Study Reveals Hidden Impact of Artificial Intelligence
Read more
October 30, 2025 · 6:00 AM UTC
First Close of Emerald Global Water Fund II Reaches EUR 60 Million
Read more

CEO
Christophe Beck
Compensation Summary
(Year 2024)

CEO
Christophe Beck
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2003-06-09 | Forward | 2:1 |
| 1998-01-16 | Forward | 2:1 |
| 1994-01-19 | Forward | 2:1 |
| 1986-07-16 | Forward | 2:1 |
Ratings Snapshot
Rating : B
Most Recent Analyst Grades

Stifel
Buy

Citigroup
Buy

Seaport Global
Buy

Evercore ISI Group
Outperform

BMO Capital
Outperform

Baird
Outperform

Mizuho
Outperform

RBC Capital
Outperform

Barclays
Overweight

Piper Sandler
Overweight

Morgan Stanley
Overweight

Wells Fargo
Equal Weight

UBS
Neutral

JP Morgan
Neutral

Redburn Atlantic
Neutral
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
25.19M Shares
$6.931B

BLACKROCK, INC.
22.643M Shares
$6.231B

BLACKROCK INC.
21.747M Shares
$5.984B

STATE STREET CORP
11.206M Shares
$3.083B

MORGAN STANLEY
7.441M Shares
$2.048B

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
6.954M Shares
$1.913B

JPMORGAN CHASE & CO
6.492M Shares
$1.786B

GEODE CAPITAL MANAGEMENT, LLC
5.589M Shares
$1.538B

BILL & MELINDA GATES FOUNDATION TRUST
5.218M Shares
$1.436B

PICTET ASSET MANAGEMENT SA
4.251M Shares
$1.17B

PICTET ASSET MANAGEMENT HOLDING SA
4.141M Shares
$1.139B

BLACKROCK FUND ADVISORS
4.086M Shares
$1.124B

ARISTOTLE CAPITAL MANAGEMENT, LLC
4.071M Shares
$1.12B

ROYAL BANK OF CANADA
3.623M Shares
$996.937M

UBS ASSET MANAGEMENT AMERICAS INC
3.428M Shares
$943.173M

PICTET ASSET MANAGEMENT LTD
3.398M Shares
$935.031M

NORGES BANK
3.146M Shares
$865.536M

NORTHERN TRUST CORP
2.928M Shares
$805.598M

FMR LLC
2.68M Shares
$737.449M

FRANKLIN RESOURCES INC
2.651M Shares
$729.426M
Summary
Only Showing The Top 20



